Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease

Laboratory Investigation

Volumn 89, Issue 3, 2009, Pages 337-346

  Rudnicki, Michael ^a   Perco, Paul ^b,c   Enrich, Julia ^a   Eder, Susanne ^a   Heininger, Dorothea ^a   Bernthaler, Andreas ^d   Wiesinger, Martin ^d   Sarközi, Rita ^a   Noppert, Susie Jane ^a   Schramek, Herbert ^a   Mayer, Bernd ^d   Oberbauer, Rainer ^b,c   Mayer, Gert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b KH Elisabethinen ^*  (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Emergentec Biodevelopment GmbH   (Austria)

Author keywords

Genomics; Hypoxia; Microarray; Proximal tubule cells; Systems biology; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P21; SOMATOMEDIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; ATROPHY; CELL ISOLATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIUM CELL; FIBROSING ALVEOLITIS; FOLLOW UP; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GLOMERULOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE; LASER CAPTURE MICRODISSECTION; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SYSTEMS BIOLOGY; TISSUE SECTION; UPREGULATION;

EID: 61349193079     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.158     Document Type: Article

References (40)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
2. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
3. Zoja C, Benigni A, Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 2004;13:31-37.
4. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005;67:404-419.
5. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 2006;33:989-996.
6. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
7. Drumm K, Bauer B, Freudinger R, et al. Albumin induces NF-kappaB expression in human proximal tubule-derived cells (IHKE-1). Cell Physiol Biochem 2002;12:187-196.
8. Rudnicki M, Eder S, Perco P, et al. Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int 2007;71:325-335.
9. Zoja C, Benigni A, Remuzzi G. Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators. Exp Nephrol 1999;7:420-428.
10. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 1999;277:F624-F633.
11. Wang S, de Caestecker M, Kopp J, et al. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 2006;17:2504-2512.
12. Ostendorf T, Rong S, Boor P, et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:1054-1062.
13. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
14. Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015-8020.
15. Schmid H, Boucherot A, Yasuda Y, et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006;55:2993-3003.
16. Rudnicki M, Eder S, Schratzberger G, et al. Reliability of t7-based mRNA linear amplification validated by gene expression analysis of human kidney cells using cDNA microarrays. Nephron Exp Nephrol 2004;97:e86-e95.
17. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-371.
18. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
19. Diehn M, Sherlock G, Binkley G, et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003;31:219-223.
20. Hoffmann R, Valencia A. A gene network for navigating the literature. Nat Genet 2004;36:664.
21. Mi H, Guo N, Kejariwal A, et al. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 2007;35:D247-D252.
22. Pollack V, Sarkozi R, Banki Z, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol 2007;293:F1714-F1726.
23. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004;65:2003-2017.
24. Goldman CK, Kim J, Wong WL, et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993;4:121-133.
25. Gruden G, Araf S, Zonca S, et al. IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism. Kidney Int 2003;63:1249-1255.
26. Kedar D, Baker CH, Killion JJ, et al. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 2002;8:3592-3600.
27. Menu E, Kooijman R, Van Valckenborgh E, et al. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer 2004;90:1076-1083.
28. Rabelink TJ, Wijewickrama DC, de Koning EJ. Peritubular endothelium: the Achilles heel of the kidney? Kidney Int 2007;72:926-930.
29. Eckardt KU, Bernhardt W, Willam C, et al. Hypoxia-inducible transcription factors and their role in renal disease. Semin Nephrol 2007;27:363-372.
30. Bernhardt WM, Warnecke C, Willam C, et al. Organ protection by hypoxia and hypoxia-inducible factors. Methods Enzymol 2007;435:221-245.
31. Orphanides C, Fine LG, Norman JT. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 1997;52:637-647.
32. Kietzmann T, Samoylenko A, Roth U, et al. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 2003;101:907-914.
33. Higgins DF, Biju MP, Akai Y, et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004;287:F1223-F1232.
34. Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007;117:3810-3820.
35. Goda N, Ryan HE, Khadivi B, et al. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003;23:359-369.
36. Tanaka T, Miyata T, Inagi R, et al. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 2004;165:1979-1992.
37. Lindenmeyer MT, Kretzler M, Boucherot A, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007;18:1765-1776.
38. Ema M, Taya S, Yokotani N, et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997;94:4273-4278.
39. Hu CJ, Iyer S, Sataur A, et al. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol 2006;26:3514-3526.
40. Xia G, Kageyama Y, Hayashi T, et al. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. Cancer 2001;91:1429-1436.